PD-0299685
PD-0299685 is a gabapentinoid (α 2 δ subunit-containing voltage-gated calcium channel blocker) which was under development for the treatment of insomnia and vasomotor symptoms (hot flashes) related to menopause as well as interstitial…
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
PD-0299685 is a gabapentinoid (α 2 δ subunit-containing voltage-gated calcium channel blocker) which was under development for the treatment of insomnia and vasomotor symptoms (hot flashes) related to menopause as well as interstitial cystitis. It is taken orally. PD-0299685 was under development by Pfizer. It reached phase 2 clinical trials prior to the discontinuation of its development.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1361139279 under CC BY-SA 4.0; modifications have been made.